Very busy weekend for EYE with the Women in Ophthalmology Conference. This conference is especially important for EYE, given its highly successful “Superwomen” marketing campaign, which has helped attract significant interest from both female and male ophthalmologists who appreciate the social impact this company is having for the field.
Looks like their booth was packed as usual by very interested new customers, and once again great to see their follower account on LinkedIn quickly rising compared to last time I checked. Each of those doctors are worth over $50k per year
EYE Summary (August 2024): Incredibly Undervalued, page-367
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
-0.010(6.06%) |
Mkt cap ! $35.50M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 16.5¢ | 15.5¢ | $58.82K | 372.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14029 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 83525 | 2 |
View Market Depth
| Last trade - 15.44pm 04/11/2024 (20 minute delay) ? |
| EYE (ASX) Chart |